Jul 23, 2015
News & Media: All
Jul 23, 2015
Precision’s Dan Renick and Larry Blandford discuss the implications of the new provider-driven value assessment tools in oncology in the July issue of Value Based Cancer Care magazine. Read more here.
Jul 9, 2015
Tomas Philipson's latest Forbes.com Op-Ed examines California's recently enacted vaccination mandate, and the application of economic epidemiology.
To read his column, please click here.
Jul 6, 2015
Precision Associate Director and Senior Research Epidemiologist Thanh Ton has been selected by the National Institutes of Health to teach data management and analysis at the NIH/Fogarty Global Health Program for Scholars and Fellows, to be held July 10-15th in Bethesda, MD. This is Dr. Ton's thi ...
Precision is proud to announce that founding partner Dana Goldman has been elected to ISPOR's Board of Directors, effective July 1st, 2015. The Board of Directors are elected by ISPOR members – over 9,500 global members were given the opportunity to vote for nominated candidates.
The Intern ...
Jun 24, 2015
Look for a quote from founding partner Tomas Philipson in the 2015 edition of Scientific American worldVIEW. Commenting on innovative medicines, Dr. Philipson anchors the lead editorial of Stacey L. Worth, Director of Public Policy, The Alliance for the Adoption of Innovations in Medicine.
To d ...
Jun 12, 2015
Precision will be looking for you at the 2015 BIO International Convention in Philadelphia, PA!
Our thought leaders will be participating in a number of panels, including:
Tuesday, June 16th, 10am—11:15am:
Panel - "Ensuring Patient Access to Innovative Medicines"
•Moderator: Christi Shaw ...
Jun 11, 2015
(from Medscape Medical News)
Miriam E. Tucker
BOSTON — Among US Medicare beneficiaries with type 2 diabetes, out-of-pocket expenses diminish adherence to medication and may end up increasing overall healthcare costs in the long run, a new study finds.
The results, from an analysis of Medica ...
May 29, 2015
Look for us at ASCO this week in Chicago-- Precision will be presenting two posters as well as hosting an exhibitor booth.
Precision Health Economics founding partner Tomas Philipson will be presenting his poster, "The relationship between breast cancer progression and workplace productivity i ...
May 28, 2015
Precision for Medicine’s Larry Blandford was quoted in the Wall Street Journal article: “New Push Ties Cost of Drugs to How Well They Work.” The effort is part of a growing push for so-called pay-for-performance deals amid complaints about the rising price of medications, some of which ...
May 27, 2015
Precision Advisors (www.precisionadvisors.com), a Precision for Medicine Company, announced the findings from its 2015 Digital Trends Study of 145 managed care executives. The study concludes that decision makers are aware of the concepts of big data and predictive analytics, but are not equippe ...
May 20, 2015
Precision is very pleased to announce that Dr. Anupam Jena has been awarded ISPOR's Bernie J. O’Brien New Investigator Award for 2015. The award was announced this week in association with ISPOR's 20th Annual International Meeting, being held in Philadelphia, PA.
The New Investigator Award w ...
May 14, 2015
Once again, Precision will have a very strong presence at ISPOR's 20th Annual International Meeting, to be held May 18th-20th at the Philadelphia Convention Center, participating in a number of notable panels, podium and poster presentations.
Precision has two booths on the show floor – on ...
May 13, 2015
PHE's Darius Lakdawalla recently sat down to discuss the economic benefits of cancer drugs with the editors of the Countering-Cancer.org series-- featuring 100 Reports from the Frontline.
To read the complete interview (#69), please click here.
May 11, 2015
Tomas Philipson's latest Forbes.com Op-Ed examines Non-Adherance in Healthcare.
May 8, 2015
PHE Founding Partner Dana Goldman and Senior Research Economist Karen Van Nuys, along with co-authors Victor J Dzau, Geoffrey S Ginsburg and David Agus, address new developments in personalized medicine in the latest edition of The Lancet.
For a link to their work in The Lancet, please click here.
May 7, 2015
Dan Renick, RPh, President of Precision for Value, a unit of Precision for Medicine, discusses the value of specialized treatments in precision medicine in the latest edition of Managed Healthcare Executive.
To read the complete article, please click here.
Apr 30, 2015
PHE's Dana Goldman and Darius Lakdawalla, along with co-author Lee Newcomer, argue for an updated value-based payment system in Oncology in the latest edition of Health Affairs' blog.
To view the complete article, please click here.
Apr 27, 2015
Los Angeles, CA, April 27, 2015—Precision Health Economics (PHE), a Precision for Medicine company, announced today the hiring of James Baumgardner, PhD, as Senior Research Economist. Joining PHE from his post as Deputy Assistant Director in the Health, Retirement, and Long-Term Analysis Divi ...
Apr 16, 2015
Extends Leadership in Health Economics and Outcomes Research With a Focus on Evidence Generation in an Era of Precision Medicine
Bethesda, MD, and Los Angeles, April 16, 2015 – Precision for Medicine (Precision), a specialized services company supporting next-generation approaches to drug de ...
Apr 9, 2015
Appearing at the AMCP's Annual Meeting and Expo in San Diego, CA, PHE Founding Partner Dana Goldman pointed out that the current model for drug pricing needs to evolve and should more closely resemble other forms of intellectual property pricing, like that of software operating systems for examp ...
Apr 8, 2015
PHE Founding Partner Tomas Philipson and Senior Research Economist Warren Stevens were both featured speakers appearing at the National Press Club in Washington, DC on April 7th-- participating in a special Health Affairs briefing organized to coincide with their special issue: "The Cost and Qul ...